209 related articles for article (PubMed ID: 25893412)
1. Correlation Between Intense Postoperative Inflammatory Response and Survival of Esophageal Cancer Patients Who Underwent Transthoracic Esophagectomy.
Matsuda S; Takeuchi H; Kawakubo H; Fukuda K; Nakamura R; Takahashi T; Wada N; Saikawa Y; Kitagawa Y
Ann Surg Oncol; 2015 Dec; 22(13):4453-60. PubMed ID: 25893412
[TBL] [Abstract][Full Text] [Related]
2. Preoperative Glasgow Prognostic Score as additional independent prognostic parameter for patients with esophageal cancer after curative esophagectomy.
Lindenmann J; Fink-Neuboeck N; Avian A; Pichler M; Habitzruther M; Maier A; Smolle-Juettner FM
Eur J Surg Oncol; 2017 Feb; 43(2):445-453. PubMed ID: 27839896
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of postoperative recovery of serum albumin levels in patients with esophageal cancer who underwent transthoracic esophagectomy.
Matsuda S; Niihara M; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Tsushima T; Yasui H; Takeuchi H; Kitagawa Y
Surg Today; 2016 Oct; 46(10):1138-45. PubMed ID: 26818192
[TBL] [Abstract][Full Text] [Related]
4. Inflammation-based prognostic system predicts postoperative survival of esophageal carcinoma patients with normal preoperative serum carcinoembryonic antigen and squamous cell carcinoma antigen levels.
Ma Q; Liu W; Jia R; Jiang F; Duan H; Lin P; Zhang L; Long H; Zhao H; Ma G
World J Surg Oncol; 2016 May; 14():141. PubMed ID: 27151090
[TBL] [Abstract][Full Text] [Related]
5. An audit of surgical outcomes of esophageal squamous cell carcinoma.
Goan YG; Chang HC; Hsu HK; Chou YP
Eur J Cardiothorac Surg; 2007 Mar; 31(3):536-44. PubMed ID: 17222561
[TBL] [Abstract][Full Text] [Related]
6. Prediction of major postoperative complications and survival for locally advanced esophageal carcinoma patients.
Sunpaweravong S; Ruangsin S; Laohawiriyakamol S; Mahattanobon S; Geater A
Asian J Surg; 2012 Jul; 35(3):104-9. PubMed ID: 22884266
[TBL] [Abstract][Full Text] [Related]
7. CXCR2 expression and postoperative complications affect long-term survival in patients with esophageal cancer.
Nishi T; Takeuchi H; Matsuda S; Ogura M; Kawakubo H; Fukuda K; Nakamura R; Takahashi T; Wada N; Saikawa Y; Omori T; Kitagawa Y
World J Surg Oncol; 2015 Aug; 13():232. PubMed ID: 26231560
[TBL] [Abstract][Full Text] [Related]
8. Cumulative prognostic scores based on plasma fibrinogen and serum albumin levels in esophageal cancer patients treated with transthoracic esophagectomy: comparison with the Glasgow prognostic score.
Matsuda S; Takeuchi H; Kawakubo H; Fukuda K; Nakamura R; Takahashi T; Wada N; Saikawa Y; Omori T; Kitagawa Y
Ann Surg Oncol; 2015 Jan; 22(1):302-10. PubMed ID: 24952029
[TBL] [Abstract][Full Text] [Related]
9. Role of Postoperative C-Reactive Protein Levels in Predicting Prognosis After Surgical Treatment of Esophageal Cancer.
Ibuki Y; Hamai Y; Hihara J; Emi M; Taomoto J; Furukawa T; Yamakita I; Kurokawa T; Okada M
World J Surg; 2017 Jun; 41(6):1558-1565. PubMed ID: 28120093
[TBL] [Abstract][Full Text] [Related]
10. Impact of neoadjuvant chemoradiotherapy on postoperative course after curative-intent transthoracic esophagectomy in esophageal cancer patients.
Bosch DJ; Muijs CT; Mul VE; Beukema JC; Hospers GA; Burgerhof JG; Plukker JT
Ann Surg Oncol; 2014 Feb; 21(2):605-11. PubMed ID: 24100962
[TBL] [Abstract][Full Text] [Related]
11. Risk factors that influence early death due to cancer recurrence after extended radical esophagectomy with three-field lymph node dissection.
Kosugi S; Kanda T; Yajima K; Ishikawa T; Hatakeyama K
Ann Surg Oncol; 2011 Oct; 18(10):2961-7. PubMed ID: 21499809
[TBL] [Abstract][Full Text] [Related]
12. Comparison of survival and recurrence pattern between two-field and three-field lymph node dissections for upper thoracic esophageal squamous cell carcinoma.
Shim YM; Kim HK; Kim K
J Thorac Oncol; 2010 May; 5(5):707-12. PubMed ID: 20421764
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological characteristics and prognosis of patients with esophageal carcinoma invading adjacent structures found during esophagectomy.
Kosugi S; Ichikawa H; Kanda T; Yajima K; Ishikawa T; Hatakeyama K
J Surg Oncol; 2012 Jun; 105(8):767-72. PubMed ID: 22473575
[TBL] [Abstract][Full Text] [Related]
14. Impact of inflammation-based prognostic score on survival after curative thoracoscopic esophagectomy for esophageal cancer.
Hirahara N; Matsubara T; Hayashi H; Takai K; Fujii Y; Tajima Y
Eur J Surg Oncol; 2015 Oct; 41(10):1308-15. PubMed ID: 26235238
[TBL] [Abstract][Full Text] [Related]
15. Primary mucoepidermoid carcinoma of the esophagus.
Chen S; Chen Y; Yang J; Yang W; Weng H; Li H; Liu D
J Thorac Oncol; 2011 Aug; 6(8):1426-31. PubMed ID: 21587086
[TBL] [Abstract][Full Text] [Related]
16. Salvage Esophagectomy After Definitive Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Who Really Benefits from this High-Risk Surgery?
Watanabe M; Mine S; Nishida K; Yamada K; Shigaki H; Matsumoto A; Sano T
Ann Surg Oncol; 2015 Dec; 22(13):4438-44. PubMed ID: 25862582
[TBL] [Abstract][Full Text] [Related]
17. Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy.
Tapias LF; Mathisen DJ; Wright CD; Wain JC; Gaissert HA; Muniappan A; Lanuti M; Donahue DM; Morse CR
Ann Thorac Surg; 2016 Mar; 101(3):1097-103. PubMed ID: 26652140
[TBL] [Abstract][Full Text] [Related]
18. Incidence and management of chylothorax after Ivor Lewis esophagectomy for cancer of the esophagus.
Brinkmann S; Schroeder W; Junggeburth K; Gutschow CA; Bludau M; Hoelscher AH; Leers JM
J Thorac Cardiovasc Surg; 2016 May; 151(5):1398-404. PubMed ID: 26936011
[TBL] [Abstract][Full Text] [Related]
19. Patterns of lymph node metastasis and survival for upper esophageal squamous cell carcinoma.
Jang HJ; Lee HS; Kim MS; Lee JM; Zo JI
Ann Thorac Surg; 2011 Sep; 92(3):1091-7. PubMed ID: 21704967
[TBL] [Abstract][Full Text] [Related]
20. The implementation of minimally-invasive esophagectomy does not impact short-term outcome in a high-volume center.
Schwameis K; Ba-Ssalamah A; Wrba F; Birner P; Prager G; Hejna M; Schmid R; Asari R; Zacherl J; Schoppmann SF
Anticancer Res; 2013 May; 33(5):2085-91. PubMed ID: 23645759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
